Table 1 Comparison between favorable and unfavorable outcomes in patients receiving EVT
|  | All patients | mRS 0–2 (n = 32) | mRS 3–6 (n = 28) | P |
|---|---|---|---|---|
Age | 71.2±11.8 | 68.4±11.3 | 74.4±11.6 | 0.04 |
Male sex | 34 (56.7%) | 23 (71.9%) | 11 (39.3%) | 0.01 |
Hypertension | 39 (65.0%) | 19 (59.4%) | 20 (71.4%) | 0.33 |
Diabetes mellitus | 22 (36.7%) | 11 (34.4%) | 11 (39.3%) | 0.69 |
Hyperlipidemia | 33 (55.0%) | 17 (53.1%) | 16 (57.1%) | 0.76 |
Atrial fibrillation | 37 (61.7%) | 16 (50.0%) | 21 (75.0%) | 0.046 |
tPA administration | 16 (26.7%) | 7 (21.9%) | 9 (32.1%) | 0.37 |
NIHSS | 16.3±6.9 | 15.1±6.3 | 17.7±7.5 | 0.18 |
Stroke subtype | Â | Â | Â | 0.59 |
 Cardioembolism | 43 (71.7%) | 22 (68.8%) | 21 (75.0%) |  |
 Large-artery atherosclerosis | 10 (16.7%) | 5 (15.6%) | 5 (17.9%) |  |
 Others | 7 (11.7%) | 5 (15.6%) | 2 (7.1%) |  |
ICA/M1 occlusion | 44 (73.3%) | 23 (71.9%) | 21 (75.0%) | 0.78 |
Procedure time | Â | Â | Â | Â |
 Onset-to-puncture (min) | 210 (138, 360) | 239 (144, 418) | 203 (134, 278) | 0.30 |
 Onset-to-recanalized (min) | 234 (156, 391) | 259 (159, 439) | 215 (144, 336) | 0.37 |
 mTICI 2c-3 | 43 (71.7%) | 27 (84.4%) | 16 (57.1%) | 0.02 |
Neuroimaging | Â | Â | Â | Â |
 ASPECTS | 8 (7, 9) | 9 (7, 9) | 8 (7, 10) | 0.38 |
 Initial core (ml) | 20 (6, 38) | 14 (3, 26) | 26 (12, 47) | 0.03 |
 Penumbra (ml) | 64 (32, 89) | 57 (32, 79) | 65 (43, 102) | 0.40 |
 Final infarct (ml) | 13.9 (3.8, 61.4) | 8.7 (1.7, 22.4) | 24.5 (6.5, 139.1) | 0.01 |
Outcome | Â | Â | Â | Â |
 mRS score | 2 (1, 4) | 1 (1, 2) | 5 (4, 5) | <0.001 |
 Mortality | 4 (6.7%) | 0 (0%) | 4 (14.3%) | 0.04 |
 Any ICH | 20 (33.3%) | 9 (28.1%) | 11 (39.3%) | 0.36 |
 Hemorrhagic infarct | 14 (23.3%) | 7 (21.9%) | 7 (25.0%) | 0.78 |
 Parenchymal hemorrhage | 6 (10.0%) | 2 (6.3%) | 4 (14.3%) | 0.40 |